Blood dialyzer, also known as hemodialyzer or artificial kidney, is a device used to filter blood of person who is suffering from kidney damage.

Market Dynamics
of kidney diseases is increasing globally, due to rising geriatric population, urinary disorders, and changing lifestyles. According to United Nations, Department of Economic and Social Affairs, Population Division, the global population aged 60 and above increased by 68% in urban areas and by 25% in the rural areas, between 2000 and 2015. Rising geriatric population will increase the chances for kidney diseases, which will be influencing favorably for sustained growth of the blood dialyzer market over the next decade.

Request For A Sample Copy Of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/2503

Furthermore, according to National Kidney Foundation 2015, 10% of the population worldwide, is affected by chronic kidney disease (CKD), and millions die each year from lack of access to affordable treatment. According to the same source, it is projected that one in five men, and one in four women, have chronic kidney disease. Rising geriatric population and increased prevalence of chronic kidney diseases will lead to increasing demand for blood dialyzers in the global market.

Moreover, development of user-friendly and low-cost dialysis products, increasing number of dialysis centers, and effective treatments are expected to provide significant growth opportunities in the blood dialyzer market.

Blood dialyzers, also called hemodialyzer, are mainly used for the removal of excess fluid accumulated in kidney. Excess fluid is removed by creating a pressure gradient across two compartments of dialyzer. Three primary methods commonly used to gain access to the blood during hemodialysis are: intravenous catheter, arteriovenous fistula (AV), and synthetic graft. The type of access to these methods is determined by factors such as the expected time course of a patient's renal failure and the condition of vasculature of patient.

The global blood dialyzer market size was valued at US$ 4,682.7 million in 2017, and is expected to witness a CAGR of 6.1% during the forecast period (2018 – 2026).

Key features of the study:

This report provides in-depth analysis of the blood dialyzer market, market size (US$ Mn), and cumulative annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017, as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players

It profiles leading players in the global blood dialyzer market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies

Detailed Segmentation:

Global Blood dialyzer Market, By Product Type:

Reusable

Disposable

Global Blood dialyzer Market, By Dialysis Membrane Material:

Cellulose Membranes

Synthetic Membranes

Global Blood dialyzer Market, By End User:

Blood Dialyzer Market- Regional Analysis

Regional segmentation of the global blood dialyzer market comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America holds the major share due to innovative and new initiatives of key players focusing chronic kidney disease and dialysis. For instance, in April 2018, CVS Health, U.S., took a new initiative, focusing on early identification of kidney disease and awareness for home dialysis systems. As part of this initiative, CVS Health started a pivotal clinical trial to demonstrate the safety and efficacy of a new home hemodialysis device in order to obtain market clearance from FDA.

Blood Dialyzer Market- Competitive Landscape

Key players operating in the blood dialyzer market include Baxter International, Inc., Nikkiso Co. Ltd., B. Braun Medical Inc., Nipro Corporation, CVS Health., Diaverum Deutschland GmbH, NxStage Medical, Inc., Fresenius Medical Care AG & Co. KGaA, and DaVita Healthcare Partners, Inc.

Click To Read More On Blood Dialyzer Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.